PPT-Hypertension: A Risk Factor For Stroke

Shannon Harris DNP FNP Objectives Causes of hypertension Classifications of hypertension Risk factors Diagnosis Complications Management Final thoughts Hypertension The 1 modifiable risk factor for stroke. Ron Pellegrino, MD. November 20, 2015. Objectives. Become comfortable with risk factor modification and chronic management of the post stroke patient.. Review the major modifiable risk factors. HTN guidelines for long term management of ischemic stroke. . How to Fix your “HIPS” Problem. Meg Meador, MPH, . C-PHI . Director, Clinical Integration & Education, NACHC. . April . 1. , 2016. Overview. The problem of undiagnosed hypertension – “HIPS” – and why you should care!. Putting the Guidelines into Practice. Relationships. . with. commercial . interests. :. Grants/. Research. Support: . Speakers Bureau/. Honoraria. : . Consulting . Fees. : . Data . Safety. and Monitoring: . Jonathan Elliott. Royal Veterinary College. London. Landmarks for feline hypertension research at the RVC. 1992 first BSAVA Clinical Studies Trust Fund grant awarded (Penney Barber appointed - PhD). 1993 Measurement of ionised calcium using electrode methods – is low ionised calcium related to feline hypertension?. Identify . differential diagnosis of a case presented with the . symptoms . of lower limb . oedema. .. Differentiate . between different etiologies of . hypertension.. Discuss . briefly between stages of hypertension.. . Ahmed . Alquthami, MD, MHSA. Introduction. Hypertension & . Stroke. Background. Pathophysiology. Significance. Descriptive Epidemiology. Causes. Prevention and control measures. Current research. Physical and pshychosocial handicap. Lesions of brain parenchima due to pathology of cerebral circulatory system that leads to hemorrhageae or ichemic lesions. Cerebral Anatomy . Vascular circulation: Anterior and Posterior . Relationships. . with. commercial . interests. :. Grants/. Research. Support: . Speakers Bureau/. Honoraria. : . Consulting . Fees. : . Data . Safety. and Monitoring: . Disclosures. This program has . Cochrane Colloquium, Seoul. Oct 24 14:00-15:30. Room. Facilitators: Alfonso Iorio, Katrina Williams. Workshop Objectives. How prognosis would fit in the context of decision making. Estimating the baseline risk: evidence on overall prognosis. 11/4/11. Pathophysiology. Regulation of cerebral blood flow. Atherosclerosis. Risk Factors. Non-modifiable. Age. Gender. Ethnicity/Race. Family history. Modifiable. HTN. Heart . disease. Smoking. Alcohol. Hypertension . doubles the risk of cardiovascular diseases, including coronary heart disease (CHD), congestive heart failure (CHF), ischemic and hemorrhagic stroke, renal failure, and peripheral arterial disease. Abstract: within a month of event and at least 1/2nd of those who survive are left with physical disability. Identification and management of risk factors remains pivotal in reducing morbidity and mor No evidence that AF type significantly impacts stroke risk. Scandinavian follow-up study of patients treated for paroxysmal (n=855) and permanent AF (n=1126) during 2002 (mean follow-up 3.6 years) . Aim: to investigate differences in stroke risk in the two cohorts. Lead Speaker: Dr Tarek Antonios. Ambra Caruso, Kristina . Leonnet. and Dr Roy Jogiya. Today:. 2. Welcome and Reminders – Ambra Caruso. National Blood Pressure Programme – Kristina . Leonnet. Hypertension Webinar – Dr Tarek Antonios.